Loading…
Longeveron Inc. is projected to rise to $0.8339 by 2027, a +5% move from its current price of $0.7949. LGVN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.7618 | $0.7947 | $0.8291 | -0.02% |
| May 30 | $0.7484 | $0.7945 | $0.8435 | -0.05% |
| May 31 | $0.7382 | $0.7944 | $0.8548 | -0.07% |
| Jun 1 | $0.7297 | $0.7942 | $0.8643 | -0.09% |
| Jun 2 | $0.7223 | $0.794 | $0.8728 | -0.11% |
| Jun 3 | $0.7157 | $0.7938 | $0.8805 | -0.14% |
| Jun 4 | $0.7096 | $0.7936 | $0.8876 | -0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7096 | $0.7936 | $0.8876 | -0.16% |
| Week 2 | $0.6764 | $0.7924 | $0.9283 | -0.32% |
| Week 3 | $0.6517 | $0.7911 | $0.9604 | -0.47% |
| Week 4 | $0.6314 | $0.7899 | $0.9881 | -0.63% |
| Week 5 | $0.614 | $0.7886 | $1.01 | -0.79% |
| Week 6 | $0.5985 | $0.7874 | $1.04 | -0.95% |
| Week 7 | $0.5846 | $0.7861 | $1.06 | -1.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Longeveron Inc. is a clinical-stage biotechnology company focused on developing cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors, which is in phase 3 clinical trial to treat hypoplastic left heart syndrome.
The company completed phase 2a clinical trial to treat Alzheimer's disease, and phase 2b clinical trial to treat aging frailty. Longeveron was incorporated in 2014 and is headquartered in Miami, Florida.
Longeveron Inc. (LGVN) is a healthcare stock currently trading at $0.8202 with a market cap of $25.92M, and it ranks 4868 by market capitalization.
The near-term outlook reflects a neutral stance, with a technical backdrop showing the stock’s current price around a range influenced by nearby moving averages and a 30-day trading window. The longer-term forecast envisions meaningful upside, with the average price projected to rise to $1.45 by 2030 and to $5.16 by 2050, accompanied by substantial max-price forecasts and rising ROI through the horizon.
Forecasts indicate bullish sentiment in the later years, with max price projections reaching $11.83 by 2050 and ROI climbing to 529.2%. These figures underscore the potential for upside over multi-year horizons, though these are projections and carry inherent uncertainty.
A major floor 48.0% below — a decisive break under it would weaken the trend.
The nearest floor, 15.6% below — buyers have tended to step in here.
The nearest ceiling, 40.9% above — a clean break opens room to run.
A major ceiling 64.9% above — clearing it would confirm fresh momentum.
Key LGVN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LGVN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7708 | Buy | $0.7767 | Buy |
| MA 10 | $0.7332 | Buy | $0.7687 | Buy |
| MA 20 | $0.7889 | Buy | $0.8007 | Sell |
| MA 50 | $0.9337 | Sell | $0.8368 | Sell |
| MA 100 | $0.7617 | Buy | $0.8176 | Sell |
| MA 200 | $0.7479 | Buy | $0.9543 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.49 | Neutral |
| Stoch RSI (14) | 87.98 | Sell |
| CCI (20) | 6.26 | Neutral |
| Williams %R (14) | -31.49 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -5.92 | Sell |
| Bollinger %B (20,2) | 0.52 | Neutral |
| Stochastic %K (14) | 68.51 | Neutral |
| TRIX (15) | -0.99 | Sell |
| Awesome (5,34) | -0.12 | Sell |
| Ultimate (7,14,28) | 63.70 | Neutral |
| Momentum (10) | 0.05 | Buy |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 0.83 | Sell |
| ADX (14) | 25.53 | Sell |
| ATR (14) | 0.03 | Info |
The 30-day range for LGVN is $0.6104 to $1.10, illustrating a modest swing around the current level. The stock’s technicals show an RSI of 50, with a SMA50 of $0.9388 and a SMA200 of $0.7496, suggesting the price is hovering around key moving averages.
Support is quoted at $0.671 and resistance at $1.12, framing a near-term trading band. Overall near-term sentiment is NEUTRAL.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.484 | $0.7949 | $1.02 | 0% | Neutral | |
| $0.6261 | $0.8339 | $1.19 | +5% | Neutral | |
| $0.6731 | $0.9375 | $1.41 | +18% | Neutral | |
| $0.7567 | $1.09 | $1.72 | +38% | Bullish | |
| $0.9102 | $1.36 | $2.21 | +71% | Bullish | |
| $0.8975 | $1.39 | $2.32 | +75% | Bullish | |
| $0.8165 | $1.30 | $2.23 | +64% | Bullish | |
| $0.8441 | $1.38 | $2.43 | +74% | Bullish | |
| $0.7796 | $1.31 | $2.35 | +65% | Bullish | |
| $0.9984 | $1.73 | $3.16 | +117% | Bullish | |
| $0.9979 | $1.96 | $3.89 | +146% | Bullish | |
| $2.09 | $4.65 | $10.36 | +485% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.484 | $0.7949 | $0.945 | +0.00% |
| June 2026 | $0.6903 | $0.8205 | $1.01 | +3.22% |
| July 2026 | $0.6465 | $0.7786 | $0.9739 | -5.10% |
| August 2026 | $0.6149 | $0.7483 | $0.9507 | -3.89% |
| September 2026 | $0.6281 | $0.7711 | $0.992 | +3.04% |
| October 2026 | $0.6203 | $0.7675 | $0.9986 | -0.47% |
| November 2026 | $0.5909 | $0.7362 | $0.9675 | -4.07% |
| December 2026 | $0.6101 | $0.7653 | $1.02 | +3.95% |
Click any year to see its month-by-month LGVN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Longeveron Inc.'s 2026 outlook centres on $0.7949, within a $0.484 to $1.02 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, LGVN could reach as high as $1.19, with a base case around $0.8339 and support toward $0.6261 — roughly +5% from $0.7949. A consolidation phase looks the most probable path here.
Expect LGVN to range from $0.6731 to $1.41 through 2028. The $0.9375 average target implies a +18% move from current prices. That is up +12% on the projected 2027 average. Price action looks broadly range-bound.
The LGVN price prediction for 2029 points to an average of $1.09 (low $0.7567, high $1.72) — a potential gain of +38% on today's $0.7949. Buyers look set to stay in control over this stretch.
In 2030, LGVN is projected to trade between $0.9102 and $2.21, averaging $1.36 — a potential gain of +71% from today's $0.7949. That is up +24% on the projected 2029 average. Momentum favours further upside here.
Longeveron Inc.'s 2031 outlook centres on $1.39, within a $0.8975 to $2.32 range. That is up +2% on the projected 2030 average. That marks a +75% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, LGVN could reach as high as $2.23, with a base case around $1.30 and support toward $0.8165 — roughly +64% from $0.7949. Momentum favours further upside here.
Expect LGVN to range from $0.8441 to $2.43 through 2033. The $1.38 average target implies a +74% move from current prices. That is up +6% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The LGVN price prediction for 2034 points to an average of $1.31 (low $0.7796, high $2.35) — a potential gain of +65% on today's $0.7949. Momentum favours further upside here.
In 2035, LGVN is projected to trade between $0.9984 and $3.16, averaging $1.73 — a potential gain of +117% from today's $0.7949. That is up +32% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Longeveron Inc.'s 2040 outlook centres on $1.96, within a $0.9979 to $3.89 range. That is up +13% on the projected 2035 average. That marks a +146% change versus current levels. Momentum favours further upside here.
By 2050, LGVN could reach as high as $10.36, with a base case around $4.65 and support toward $2.09 — roughly +485% from $0.7949. Buyers look set to stay in control over this stretch.
Investing $1,000 in LGVN today (≈ 1,258.019877 LGVN) could be worth
$5,848.21
+$4,848.21 (+485%) by 2050 · US Dollar
Based on the average projected LGVN price of $4.65 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LGVNwould be worth at today's price.
$1,000 invested in LGVN on May 27, 2025 (≈ 746.268638 LGVN) would be worth
$593.21
-$406.79 (-40.7%) today · 0.59× · US Dollar
Based on a LGVN entry price of $1.34 vs. today's $0.7949.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.707 | $1,124.33 | +12.4% |
| 1 month ago | $0.9 | $883.22 | -11.7% |
| 3 months ago | $0.58 | $1,370.52 | +37.1% |
| 6 months ago | $0.664 | $1,197.14 | +19.7% |
| 1 year ago | $1.34 | $593.21 | -40.7% |
| All time (5.0y) ago | $67.7 | $11.74 | -98.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LGVN forecast.
Our base-case forecast reaches $1.60 around 2035.
Implied market cap at $1.60: $48.24M
The multi-year forecast suggests a bullish trajectory beginning in the late 2020s and extending through 2030 and beyond. The 2030 average price is $1.45 with a 77.3% ROI, while the 2040 average rises to $2.08 with a 154.2% ROI, and the 2050 average reaches $5.16 with a 529.2% ROI. The forecast also shows growing max-price potential, with 2050 peaking at $11.83.
Key milestones in the forecast include continued bullish sentiment from 2029 onward, supported by projected price and ROI expansion across the 2030s and 2040s. The indicators note an annualized volatility of 90%, highlighting notable risk and variability alongside the upside potential. In the longer run, the lead product LOMECEL-B in phase 3 for HLHS is a driver cited in the provided forecast, but these projections remain estimates with inherent uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.45 with a max of $2.40 and a min of $0.9531, corresponding to a 77.3% ROI. The sentiment is BULLISH for 2030.
Forecasts indicate neutral sentiment in the near term (2026–2028) turning bullish from 2029 onward, with the average price rising to $1.45 by 2030 and a 77.3% ROI; by 2050 the forecast envisions an average price of $5.16 and a 529.2% ROI, acknowledging that these are estimates, not guarantees.
Yes. The forecast projects an average price of $5.16 by 2050 and a max of $11.83, indicating potential for substantial upside over the long term.
LGVN is currently priced at $0.8202 with a market cap of $25.92M.
The 30-day range is $0.6104 to $1.10.
Longeveron Inc. Community Discussion
0Share your Longeveron Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.